Ratings by BTIG (Yun Zhong)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 3/6/2023 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
| 2/8/2023 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2023 | Taysha Gene Therapies | TSHA | Downgrade | Neutral (Buy) |
1.64 (6.34) |
286.59% | Details | |
| 1/26/2023 | Magenta Therapeutics | MGTA | Downgrade | Neutral (Buy) |
0.50 (0.70) |
40% | Details | |
| 1/24/2023 | Graphite Bio Inc | GRPH | Downgrade | Neutral (Buy) |
1.94 (3.18) |
63.92% | Details | |
| 1/17/2023 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 12/22/2022 | Rocket Pharmaceuticals | RCKT | Maintain | Buy (N/A) |
|
Details | ||
| 12/21/2022 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 12/20/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
| 12/8/2022 | Avrobio Inc. | AVRO | Upgrade | Buy (Neutral) |
0.84 (1.40) |
66.67% | Details | |
| 12/2/2022 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 11/16/2022 | Freeline | FRLN | Maintain | Buy (N/A) |
|
Details | ||
| 11/11/2022 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
| 11/9/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 9/29/2022 | Applied Genetic Technologies Corp. | AGTC | Downgrade | Neutral (Buy) |
0.30 (0.39) |
30% | Details | |
| 9/21/2022 | Renovacor, Inc. | RCOR | Downgrade | Neutral (Buy) |
1.90 (3.20) |
68.42% | Details | |
| 8/11/2022 | uniQure BV | QURE | Maintain | Buy (N/A) |
|
Details | ||
| 5/18/2022 | Applied Genetic Technologies Corp. | AGTC | Maintain | Buy (N/A) |
|
Details | ||
| 5/17/2022 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
| 5/9/2022 | Mereo BipPharma Group | MREO | Maintain | Buy (N/A) |
|
Details | ||
| 4/18/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
| 4/14/2022 | Graphite Bio Inc | GRPH | New Coverage | Buy (N/A) |
4.15 (3.18) |
-23.37% | Details | |
| 4/1/2022 | Taysha Gene Therapies | TSHA | Maintain | Buy (N/A) |
|
Details | ||
| 3/9/2022 | Magenta Therapeutics | MGTA | Maintain | Buy (N/A) |
|
Details | ||
| 2/24/2022 | Amicus Therapeutics | FOLD | Maintain | Buy (N/A) |
|
Details | ||
| 2/10/2022 | Anavex Life Sciences | AVXL | Maintain | Buy (N/A) |
|
Details | ||
| 2/2/2022 | Sio Gene Therapies | SIOX | Maintain | Buy (N/A) |
|
Details | ||
| 1/18/2022 | Passage Bio Inc. | PASG | Maintain | Buy (N/A) |
|
Details | ||
| 1/5/2022 | Avrobio Inc. | AVRO | Downgrade | Neutral (Buy) |
4.04 (1.40) |
-65.35% | Details | |
| 10/11/2021 | Sarepta Therapeutics | SRPT | Maintain | Buy (N/A) |
|
Details | ||
| 9/23/2021 | Anavex Life Sciences | AVXL | New Coverage | Buy (N/A) |
17.64 (2.62) |
-85.15% | Details | |
| 7/19/2021 | Amicus Therapeutics | FOLD | New Coverage | Buy (N/A) |
9.30 (14.49) |
55.81% | Details | |
| 6/15/2021 | Taysha Gene Therapies | TSHA | New Coverage | Buy (N/A) |
24.51 (6.34) |
-74.13% | Details | |
| 6/15/2021 | uniQure BV | QURE | New Coverage | Buy (N/A) |
36.06 (47.51) |
31.75% | Details | |
| 6/15/2021 | Sio Gene Therapies | SIOX | New Coverage | Buy (N/A) |
2.49 (0.42) |
-83.13% | Details | |
| 6/15/2021 | Sarepta Therapeutics | SRPT | New Coverage | Buy (N/A) |
86.00 (16.85) |
-80.41% | Details | |
| 6/15/2021 | Passage Bio Inc. | PASG | New Coverage | Buy (N/A) |
14.11 (4.70) |
-66.69% | Details | |
| 6/15/2021 | Magenta Therapeutics | MGTA | New Coverage | Buy (N/A) |
11.58 (0.70) |
-93.96% | Details | |
| 6/15/2021 | Avrobio Inc. | AVRO | New Coverage | Buy (N/A) |
9.54 (1.40) |
-85.32% | Details | |
| 5/5/2021 | Mereo BipPharma Group | MREO | New Coverage | Buy (N/A) |
3.49 (1.29) |
-63.04% | Details |
